RARE DISEASERESEARCH ATLAS

ORPHA:1388

Pierre-Robin sequence-Manzke dysostosis-clinodactyly of the index finger syndrome

low confidenceDisorder

Also known as: Pierre-Robin sequence-hyperphalangy and clinodactyly of the index finger syndrome

Publications

656

Trials

0

Interventional, condition-specific

Researchers

1,174

Distinct authors in sample

Gene link

TGDS

Definitive

Readiness

4/6

Stages with a signal

Clinical definition (Orphanet)

Catel-Manzke syndrome is a rare bone disease characterized by bilateral hyperphalangy and clinodactyly of the index finger typically in association with Pierre Robin sequence comprising micrognathia, cleft palate and glossoptosis.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (8)

Catel Manzke Syndrome · Catel-Manzke syndrome · Palatodigital syndrome, Catel-Manzke type · Pierre Robin sequence-hyperphalangy-clinodactyly syndrome · Pierre Robin syndrome-hyperphalangy-clinodactyly syndrome · hyperphalangy-clinodactyly of index finger with Pierre Robin syndrome · index finger anomaly-Pierre Robin syndrome · micrognathia digital syndrome

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

4/6 stages with a signal

No matched interventional trial, but a gene association and an animal model are on record — often described as translation-ready / stalled at the clinical step.

  1. Gene identifiedPresent

    Definitive — TGDS

  2. LiteraturePresent

    656 matched papers (443 in last 10 years) Source

  3. Phenotype characterisedPresent

    73 HPO annotations (e.g. Micrognathia; Abnormal epiphysis morphology; Chronic otitis media) Source

  4. Animal modelPresent

    1 genotype model (Mus musculus) Source

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (TGDS).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

73

Associated phenotypes · MONDO:0014507

  • Micrognathia
  • Abnormal epiphysis morphology
  • Chronic otitis media
  • Joint stiffness
  • Radial deviation of the 2nd finger

Showing 5 of 73 — open Monarch for the full list.

Animal models (Monarch / Alliance)

1

Model associations linked to this Mondo ID

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

656

656 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

656 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

443 in the last 10 years · low confidence

Phrase hits: 228 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,174

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Cormier-Daire V7 papers · 2025

    Université de Paris, INSERM UMR 1163, Institut Imagine, Paris, France.

    Papers in Europe PMC
  2. 02
    Ehmke N6 papers · 2025

    Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.

    Papers in Europe PMC
  3. 03
    Mundlos S6 papers · 2025

    Institut für medizinische Genetik und Humangenetik, Charité - Universitätsmedizin Berlin, Berlin, Germany.

    Papers in Europe PMC
  4. 04
    Kornak U5 papers · 2025

    Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.

    Papers in Europe PMC
  5. 05
    Fischer-Zirnsak B4 papers · 2025

    Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.

    Papers in Europe PMC
  6. 06
    Al Kaissi A3 papers · 2013

    First Medical Department, Hanusch Hospital, Ludwig-Boltzmann Institute of Osteology, Hanusch Hospital of WGKK and AUVA Trauma Center Meidling, Vienna, Austria. ali.alkaissi@osteologie.at

    Papers in Europe PMC
  7. 07
    Campeau PM3 papers · 2026

    Department of Pediatrics, CHU Sainte-Justine Research Center, 3175 Chemin de la Côte-Sainte-Catherine, and Université de Montréal, 2900 Edouard Montpetit Boulevard, Montreal, QC, Canada, H3T1C5.

    Papers in Europe PMC
  8. 08
    Ferreira CR3 papers · 2023

    Medical Genetics Branch National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

    Papers in Europe PMC
  9. 09
    Grill F3 papers · 2013
    Papers in Europe PMC
  10. 10
    Huber C3 papers · 2020

    Department of Genetics, INSERM UMR 1163, Université Paris Descartes-Sorbonne PARIS Cité, Imagine Institute, Hôpital Necker Enfants Males, 75015 Paris, France.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Pierre-Robin sequence-Manzke dysostosis-clinodactyly of the index finger syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Pierre-Robin sequence-Manzke dysostosis-clinodactyly of the index finger syndrome" OR "Pierre-Robin sequence-Manzke dysostosis-clinodactyly of index finger syndrome" OR "Pierre-Robin sequence-hyperphalangy and clinodactyly of the index finger syndrome" OR "Pierre-Robin sequence-hyperphalangy and clinodactyly of index finger syndrome" OR "Catel Manzke Syndrome" OR "Catel-Manzke syndrome" OR "Palatodigital syndrome, Catel-Manzke type" OR "Pierre Robin sequence-hyperphalangy-clinodactyly syndrome" OR "Pierre Robin syndrome-hyperphalangy-clinodactyly syndrome" OR "hyperphalangy-clinodactyly of index finger with Pierre Robin syndrome" OR "hyperphalangy-clinodactyly of the index finger with Pierre Robin syndrome" OR "index finger anomaly-Pierre Robin syndrome" OR "micrognathia digital syndrome") OR ("TGDS" OR "TGDS syndrome" OR "TGDS-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Pierre-Robin sequence-Manzke dysostosis-clinodactyly of the index finger syndrome" OR "Pierre-Robin sequence-Manzke dysostosis-clinodactyly of index finger syndrome" OR "Pierre-Robin sequence-hyperphalangy and clinodactyly of the index finger syndrome" OR "Pierre-Robin sequence-hyperphalangy and clinodactyly of index finger syndrome" OR "Catel Manzke Syndrome" OR "Catel-Manzke syndrome" OR "Palatodigital syndrome, Catel-Manzke type" OR "Pierre Robin sequence-hyperphalangy-clinodactyly syndrome" OR "Pierre Robin syndrome-hyperphalangy-clinodactyly syndrome" OR "hyperphalangy-clinodactyly of index finger with Pierre Robin syndrome" OR "hyperphalangy-clinodactyly of the index finger with Pierre Robin syndrome" OR "index finger anomaly-Pierre Robin syndrome" OR "micrognathia digital syndrome"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (656) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-26T17:13:08.739Z